Abbey Meyers featured in Life Science Leader magazine

Magazine feature | March 1, 2016 — by Wayne Koberstein, Executive Editor, Life Science Leader magazine

Life Science Leader profiled Abbey Meyers as part of its "Industry Explorers Blaze On" series, tracing her path from a parent seeking treatment for her son's Tourette syndrome to founding NORD and driving passage of the Orphan Drug Act of 1983. The piece revisits Meyers' early clashes with the pharmaceutical industry over access and pricing, the role of the Quincy, M.E. television episodes in pushing the law through Congress, the 1996 tax-credit carry-back/carry-forward amendment that opened the door for small biotech firms, and the first patient medication-assistance program NORD built with Sandoz for Sandimmune (cyclosporine). It closes with Meyers' reflections on drug pricing and her view that the Act's core incentives should be left intact.

Read the full article on Life Science Leader's website: lifescienceleader.com.